Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would have to agree ... Thero and Cronies should be made to pay back the millions they looted from the company
Yes so then why would PFizer go ahead and invest in a new drug that is not proven in Phase 2 studies - when they have a proven winner waiting to be bought out ....
Reminds me of government workers - we need line inspectors for the roads - Believe it or not these are actual paid positions in NY - after all if you have been painting lines on the road for 20 years you might not know how to do it but wait a minute the line inspectors might not do their work so we need inspectors of inspectors ...and then inspectors of inspectors of inspectors .... and then at some point the peasants revolt
IF HIKMA knew that the would be able to continue to infringe without limitation there would be no need for this new suit. The fact that they have brought his new suit tells me that they are uncertain
So I guess for the FDA and all the experts they hired - it was nOT so obvious - which is why they required REDUCE IT study - this si nothing short of hilarious - it was obvious - thats why the FDA required a study
LM - does the fact that AMRN has refused to take action for shareholders by default give shareholders standing ? It seems to me that shareholders should be able to respond to an issue that the BOD has missed? The company has failed the shareholders - shareholders then step forward
Seems if shareholders are refused standing the next step is then to take AIM at AMRN for failing to address the issue ?
I have found cologuard to be a pain in the butt ...no pun intended
90% of the findings are false + - then the patient needs colonoscopy currently and in 3 years! - its actually increasing testing rather than decreasing it
I have 8 Insurance denials for Vascepa sitting in my inbox right now -
I believe a lot of the downward pressure is because of Pfizers / IONIS new drug that is clearly seeking to replace Vascepa and we dont have an answer why PFIZER would not seek to buy AMRN
The new med is an injection - its probably going to cost a fortune it has not yet been proven to reduce cardiac events will have more side effects than Vascepa -
WHy run down that trail full of unknowns when a clear path sits in front of you ? Doesnt make sense to me ...
Until I can understand why PFIZER is going in this direction I will be very hesitant to look for any significant escalation in stock price ...
Thanks Marjac !
From a non legal perspective I found the following definitions of interest
JUdge Du says AMRN has standing yet tries to say shareholders dont
So the employees of AMRN can bring a suit yet stockholders cant
SHe has redefined shareholders as not being stakeholders - this is a blatant falsehood
Many people have a vested interest in the success of a company. If you own a portion of it, you want it to succeed because then you get a cut of the profits. These individuals are defined as “shareholders.”
If you have a financial interest in the company other than ownership, say you work for it, you still want it to succeed. Everyone who wants the corporation to succeed is called a “stakeholder.”
Not every stakeholder is a shareholder but every shareholder is a stakeholder - except in JUdge Du's world.
If its #2 It is my opinion Judge DU does not have the character to admit her mistake and although she would recognize the cropped table she would still rule against AMRN ( ie "see I was right all along " )
Yes but they will have to lay out millions in research the research may fail etc and there sits VASCEPA - complete with FDA approval scientific evidence etc - so why wont they buy it - to me this is a huge red flag ?
Possibilities :
1.) They believe their product will be more effective
2.) They do intend to buy AMRN start with VASCEPA build the market for residual risk and then transition to their new product if the research is successful
3.) They buy into Stevie's kool aid and expect future studies with minerla oil to prove REDUCE IT wrong
4.) Cost to purchase AMRN is well beyond the risk they wish to take vs developing a new product
Its an injection - its probably going to cost a fortune it has not yet been proven to reduce cardiac events will have more side effects than Vascepa -
OK someone explain to me why they are pursuing this vs not just making VASTOR ???
NIce slide FFS !
One would have to question why a pharmaceutical firm would want to out lay the significant financial resources necessary to perform these studies with no guarantee of success vs just buying an established product with a proven study ?
Exactly I am interested in profit - loss thats it - everybody is an expert - ironic how all these experts wont actual tell you when they buy or sell - its all rather entertaining
Because the proof is in the pudding ....the only thing that matters is did you make money
Yes my last purchase is down 9% - the question is why do you cite that if you are not interested in actual profit or loss but the why ?
Please give evidence of buy and sell actions which are not retrospective in nature - I value opinions on both sides of the equation and therefore welcome yours - what I dont value stating they predicted something that is not verifiable by theri buy or sell actions
I have clearly stated when I buy and when I sell
Great ... another buying opportunity !!!
$2.77 wow great buying opportunity ...cant wait !!
Ozempic will now be strongly marketing their CVD benefits for diabetics ....
Vascepa
NRx (+456)
Generic Vascepa
NRx (+425)
ok 425 does not equal 456 .... but thats not the point
the point is NEW gV Rx's are nearly = to V
I find that disconcerting
gV now = V - this is direct evidence of infringement imho - since 90% of V's market is CAD - how can any thinking judge not view this as infringement is beyond me ....
You know I dont consider myself any form of financial expert but Id like to form a Capital Acquisition COrporation - People give me money to invest I then have an IPO and sell share at $10 but give myself a bunch at $0.005 - sell them off later at near $10 how do you lose at that game ???? Reminds me of JT and crew at AMRN
Couldn't agree more ..maybe we can borrow that big red reset button ...
There needs to be a mutifaceted approach to the US
1.) Not one more mention of fish oil
2.) Educate DOcs regarding the distinct difference between dha and epa
3.) Educate Insurers
4.) Educate the public
5.) Launch advertising campaign indicating that if you are not receiving vascepa and have known heart disease your risk of having an event just increased by 25%
I cant emphasize enough how advertising that one sentence would effect Rx numbers !
6.) Institute many more legal actions against insurers / PBM's that allow infringement
7.) They need articles in primary care journals ( Pharmacy Dude if you want to writhe one with me for American Family Physician let me know ).
the list goes on and on
Its not doing much as a stock ....
https://www.google.com/finance/quote/SRSA:NASDAQ?window=5Y
Fascinating IRONWOOD a one product company appointed DEnner ( Dr. Denner is the founding partner and chief investment officer of Sarissa Capital Management LP) to its BOD ....
https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Appoints-Alexander-Denner-Ph.D.-to-Board-of-Directors/default.aspx
dont know if anyone posted this
https://www.medscape.com/viewarticle/962972
These are exceptions average premium is about 100% which now would be about $8 https://www.evaluate.com/vantage/articles/news/snippets/biotech-deal-premiums-still-punchy
Not convinced activist investors are going to be the best for a lot of people here - say they came in at $4.xx and force a sale at $8.xx in 6 months - Great return they doubled their money in 6 mos (which also works for me ) but I know there are a lot of people here would be hurt by such an action
$7.40
16% reduction not clinically significant ....
I did a consult for some investors over the weekend on treatment of LDL - it was absolutely amazing - no awareness whatsoever of Vascepa - it was lumped together with Lovaza - their total conversation was on SGLT's and PCSK9's. I repeatedly advised then of REDUCE IT but they seemed rather oblivious - after it all its just "fish oil. "
AMRN's biggest mistake ...allowing the narrative to be managed instead of they managing it ...
All true - I believe the hope was KM would change all of that but I am not seeing it - there seems to be a lack of awareness / vitality / fight call it what you may in the ranks - when I see case after case of infringement and AMRN does nothing to address the situation I find this alarming. They should be calling out every Insurer PBM that is involved in infringement
Agree BBI I indicated I could see a dip to $3.50 - albeit not based on true value as I dont think any investor is counting on COVID success yet there will be a reaction ... and that is another buying opportunity ... no way to lose here - if the news is + great if not I can buy ....
I seem to recall he left many months ago
Have done primary care for 30 years there is absolutely NO WAY I would ever recommend anyone doing this. I use to teach medical students - I began telling them that if they wished to do primary care they should consider it a calling like being a minister or missionary. If they had a personality that allowed them to be used and abused by society - consumed by needy people - then do primary care - otherwise stay away -
Once again you would expect AMRN to be totally aware and managing these issues..
AS I think about this through the years ...say I wanted to sell a widget that I developed . I raised capital hired personnel - took the company public and I am set to go .
Do you think any business person in that scenario would have a total and complete understanding of how to sell that widget ? Afterall you could have the greatest widget in the world but if you cant sell it - what good is it ?
AMRN developed the widget and then went to sell it with no understanding of how to - dismal breakdown of lack of understanding of basic business
They really need to give doctors time just like professors - you work maybe 2- 3 hours a day then you can spend the rest of the day 'keeping up' and then once every five years you get a year off with pay to further "keep up " ....sign me up ....